Gilead to Address Investors at J.P. Morgan Healthcare Conference

Event summary

  • Gilead Sciences executives will present at the J.P. Morgan Healthcare Conference on January 12, 2026.
  • The presentation will begin at 11:15 a.m. Pacific Time.
  • A live webcast will be available at investors.gilead.com, with a replay accessible for at least 30 days.
  • The conference is a major annual gathering for healthcare investors and industry leaders.

The big picture

The J.P. Morgan Healthcare Conference is a crucial event for biopharmaceutical companies to engage with investors and shape market perception. Gilead’s participation signals a continued effort to communicate its strategic direction amidst ongoing challenges related to patent expirations and evolving competitive dynamics within the $500+ billion global biopharmaceutical market. The conference provides a platform to address investor concerns and highlight potential growth drivers.

What we're watching

Pipeline Progress
The conference presentation will likely focus on Gilead’s pipeline, particularly its oncology and inflammation programs, and investors will scrutinize the data presented for signs of accelerated development or potential setbacks.
Competitive Landscape
Given the increasing competition in Gilead’s core therapeutic areas, the presentation will be assessed for how the company plans to maintain market share and defend its intellectual property.
Financial Outlook
The market will be looking for indications of how Gilead intends to navigate potential revenue declines from existing products and whether the company will outline specific strategies for future growth and profitability.